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ABSTRACT
S.J . WADDELL, G.A . CHUNG, K.J .C . GIBSON, M.J . EVERETT, D .E . MINNIK IN , G .S . BESRA AND P.D. BUTCHER.
2005.
Aims: Phthiocerol dimycocerosate (PDIM) waxes and other lipids are necessary for successful Mycobacterium
tuberculosis infection, although the exact role of PDIM in host-pathogen interactions remains unclear. In this study,
we investigated the contribution of tesA, drrB, pks6 and pks11 genes in complex lipid biosynthesis in M. tuberculosis.
Methods and Results: Four mutants were selected from M. tuberculosis H37Rv transposon mutant library. The
transposon insertion sites were confirmed to be within the M. tuberculosis open reading frames for tesA (a probable
thioesterase), drrB (predicted ABC transporter), pks11 (putative chalcone synthase) and pks6 (polyketide synthase).
The first three of these transposon mutants were unable to generate PDIM and the fourth lacked novel polar lipids.
Conclusions: Mycobacterium tuberculosis can be cultivated in vitro without the involvement of certain lipid
synthesis genes, which may be necessary for in vivo pathogenicity.
Significance and Impact of the Study: The use of transposon mutants is a new functional genomic approach for
the eventual definition of the mycobacterial ‘lipidome’.
Keywords: cell wall, lipids, mutants, Mycobacterium tuberculosis, polyketide synthases.
INTRODUCTION
The World Health Organisation (1993), declared tuber-
culosis as a global health emergency (Najima 1996). Ten
years on, it has been estimated that the global incidence
rate of tuberculosis is growing at c. 0Æ4% per year
(WHO Report 2003). Many front line drugs target the
cell wall of Mycobacterium tuberculosis. Understanding the
role of cell envelope components may indicate new drug
targets.
Phthiocerol dimycocerosate (PDIM) waxes consist of two
multi-methyl branched mycocerosic acids esterified to
phthiocerol and they occur in a limited group of
pathogenic mycobacteria. The related phenolphthiocerol
dimycocerosates are the lipid core of the glycosyl-
phenolphthiocerol dimycocerosates, known as phenolic
glycolipids (PGL) (Minnikin et al. 2002). PGL are
present in Mycobacterium bovis and smooth ‘Canetti’
variants of the tubercle bacillus but are absent from many
M. tuberculosis strains (Constant et al. 2002; Minnikin et al.
2002).
Rainwater and Kolattukudy (1985) demonstrated the
elongation of n-fatty acyl-CoA substrates, using methyl-
malonyl-CoA to generate mycocerosic acids. The gene
encoding this methylmalonyl-specific elongation in M. bovis
BCG is the type I polyketide synthase, mas-mycocerosic
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acid synthase (Mathur and Kolattukudy 1992). The
biosynthesis of phthiocerol and phenolphthiocerol segments
of PDIM, is catalysed by products of the ppsA-E gene
cluster (Azad et al. 1997). Many of the genes responsible
for the synthesis of PDIM (mas and ppsA-E) are located in
a gene cluster of upto 15 genes, >45 kb in length (Cole
et al. 1998) (Fig. 1). Mutagenic loss of PDIM results in the
attenuation of M. tuberculosis in mouse lung (Camacho
et al. 1999; Cox et al. 1999). However, the detailed
functional significance of PDIM, during M. tuberculosis
infection, is unknown. This cluster also has genes hypo-
thesized to be involved in the production and transporta-
tion of PDIM. Genes coding for putative acyl-CoA/AMP
synthases (fadD26 and fadD28) have been implicated
in translocation during synthesis (Fitzmaurice and
Kolattukudy 1998; Trivedi et al. 2004). The drrA/B/C
genes (coding for ABC-like transporters) and mmpL7
(coding for a large conserved membrane protein) may also
be involved in the transport of PDIM (Cox et al. 1999;
Camacho et al. 2001). The roles of the remaining genes, in
the PDIM gene cluster, remain to be determined. Inter-
estingly, other members of the polyketide synthase family
have been implicated in the generation of PDIM and PGL.
For instance, pks1/15 (msl7), located downstream of the
PDIM gene cluster in M. tuberculosis, is involved in the
biosynthesis of PGL, and pks10 (a chalcone-like synthase)
has been demonstrated to be necessary for successful
PDIM synthesis (Constant et al. 2002; Sirakova et al.
2003a). Recently, the polyketide synthases coded by pks12
and pks7 have also been identified to be required for PDIM
synthesis in M. tuberculosis H37Rv (Rousseau et al. 2003;
Sirakova et al. 2003b).
Libraries of M. tuberculosis mutants derived from trans-
poson mutagenesis provide a convenient source of strains for
studying the role of particular lipids. The temperature-
sensitive bacteriophage phAE87 was used to deliver
the Tn5370 mini-transposon to generate a library of
M. tuberculosis mutants, from which the insertion points in
351 genes were defined (McAdam et al. 2002). We report
here lipid analysis from tesA (coding for a probable
thioesterase), drrB (encoding a predicted ABC transporter),
pks6 (coding for a putative polyketide synthase) and pks11
(a putative chalcone synthase) transposon mutants.
MATERIALS AND METHODS
Transposon library, PCR and sequencing
The tesA, drrB, pks6 and pks11 transposon mutants (plate
numbers 14A4, 49C4, 20F1 and 2F8 respectively) were
selected from the GlaxoSmithKline M. tuberculosis H37Rv
transposon mutant library (McAdam et al. 2002), and grown
to mid-late log phase at 37C in Dubos liquid medium,
supplemented with Bacto Dubos medium albumin. The
culture media for the transposon mutants were supplemen-
ted with 100 lg ml)1 hygromycin.
PCR was performed for the presence of Tn5370 targeting
the hygromycin resistance gene using the primers 5¢-CGG
CCC GTA CCC TGT GAA TA-3¢ (forward) and 5¢-CAC
CAG GCT GTA GCG GGA GT-3¢ (reverse). PCR
verification of the transposon insertion site was conducted
using the forward hygromycin primer with the gene-specific
primers tesA (5¢-GCC AGC TAC ATC CGG AGC AT-3¢),
drrB (5¢-CTG TGG ACC GAT GCT TCA CG-3¢), pks6
(5¢-GGG TCG CGG CAT TTT CAG TA-3¢) and pks11
(5¢-GGG GTC GAA CTA CGC AAT CG-3¢). PCR
products suitable for sequencing were generated using the SP3
primer (McAdam et al. 2002) 5¢-GCA CAC CCA AGC CAA
CCA GAC C-3¢ with the tesA, drrB, pks6 and pks11 gene
specific primers described above. The PCR products were
sequenced from the SP3 primer using the Sanger dideoxy
method of sequencing, using an ABI Prism 3100 Genetic
Analyser (Applied Biosystems, Foster City, CA, USA).
Lipid extractions
Apolar and polar lipid extracts were prepared as detailed by
Dobson et al. (1985). Apolar lipids were analysed by two-
dimensional thin layer chromatography (2D-TLC) using
four different solvent systems (A–D) and polar lipids by two
different systems (D and E) according to Dobson et al.
(1985).
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Fig. 1 The PDIM gene cluster inMycobacterium tuberculosis. Insertion sites of the transposon mutants analysed in this investigation are marked with
black triangles
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Reverse transcriptase-PCR
Reverse transcriptase (RT)-PCR protocols were adapted
from Butcher et al. (1998). DNaseI-treated RNA plus
10 lM reverse primer were incubated at 85C for 5 min,
and the samples snap-cooled. RT master mix containing: 5X
RT Buffer, dithiothreitol, dNTPs, RNaseOUTTM and
SuperScriptTM II Reverse Transcriptase (Invitrogen,
Paisley, UK) was added, and the samples incubated for
1 h at 42C. Each sample was prepared in duplicate; the
repeat lacked RT. Negative controls contained no template
or template-RNA treated with RNase A. To amplify the first
strand products, PCR was conducted using 1–2 ll of the
first strand synthesis product as template DNA. Positive
(M. tuberculosis genomic) and negative (no template DNA)
PCR controls were also performed. Products were analysed
by gel electrophoresis on 0Æ8% TBE/agarose gels using
Hyperladder I (Bioline, London, UK) electrophoresis
markers. Primers were designed to cross the intergenic
region between the tesA and Rv2929 open reading frames,
forward (5¢-ACA GTA TGG GCG GAA TGC TA-3¢),
reverse (5¢-CAC CCG AGA TGG TGC ATA C-3¢) to
generate a product of 680 bp. Control primers were
designed to amplify a 975 bp intragenic region of fadD26
(located in the PDIM gene cluster, Fig. 1), forward
(5¢-AGT TCA GAC CGG CAC GTT TG-3¢), reverse
(5¢-GCC ATG TCC TGG TCA GAT G-3¢).
RESULTS
Confirmation of the transposon insertion sites
The transposon insertion sites (McAdam et al. 2002) were
verified by three PCR strategies and sequencing. Firstly,
primers were designed to amplify an 801-bp fragment of the
hygromycin resistance gene present on the transposon. A
product of the correct size was generated with genomic
DNA from tesAD, drrBD, pks6D and pks11D; there was no
amplification using M. tuberculosis H37Rv genomic DNA.
This established that Tn5370 had indeed inserted into the
transposon mutant genomes. Secondly, primers were
designed c. 500 bp on either side of the suspected transpo-
son insertion sites. PCR was conducted using each of the
tesA, drrB, pks6 and pks11 specific primers with the
hygromycin specific primers. PCR products of the correct
size were generated with transposon mutant genomic DNA;
only nonspecific products were generated using M. tubercu-
losis genomic DNA. The use of transposon-specific, in
combination with gene-specific, primers verified that the
transposon insertion sites were within the tesA, drrB, pks6
and pks11 open reading frames, as predicted. Finally, the
PCR products (generated using the SP3 primer designed at
GSK to extend outwards from Tn5370 and the gene-specific
primers described above) from transposon mutant single
colonies picked from 7H10 plates (containing 100 lg ml)1
hygromycin) were sequenced and compared by homology
searching to the M. tuberculosis H37Rv genome. This
confirmed that the transposons were inserted into the open
reading frames of the probable thioesterase tesA, the
predicted ABC transporter drrB and the putative polyketide
synthases, pks6 and pks11.
Lipid TLC
Apolar and polar lipid fractions were extracted and
compared with WT M. tuberculosis H37Rv by 2D TLC
(Dobson et al. 1985). PDIM were missing from the tesAD,
drrBD and pks11D apolar lipid fractions (Fig. 2) but present
in pks6D. Unknown WT M. tuberculosis polar lipids were
absent in the pks6D (Fig. 2) but retained in the other
mutants (data not shown).
RT-PCR across the tesA-Rv2929 junction
RT-PCR was performed on RNA, extracted from in vitro
mid-log phase WT M. bovis BCG, to investigate the
transcriptional organization of tesA and Rv2929, located in
the PDIM gene cluster depicted in Fig. 1. Controls,
ensuring that no products were generated from contamin-
ating genomic DNA, were negative. An RT-PCR product of
the correct size was detected, using primers designed to
identify a tesA-Rv2929 intergenic sequence (Fig. 3).
DISCUSSION
The M. tuberculosis tesA transposon mutant was unable to
generate PDIM. This thioesterase is likely to be involved in
the chain termination and release of lipid products from the
multifunctional enzyme complexes in mycocerosic acid and/
or phthiocerol generation (Minnikin et al. 2002). The
product of tesA may therefore provide the thioesterase
activity proposed to be lacking in the PPSA-E and MAS
enzyme complexes. This is the first experimental confirma-
tion of the involvement of tesA in PDIM production in
mycobacteria. The experimental strategy also defines a novel
approach, using a transposon mutant library to investigate
the contribution of unknown genes in the generation of
complex lipids in M. tuberculosis. Further to the work by
Camacho et al. (2001) describing the transcriptional units of
the PDIM-gene cluster, there is an evidence from RT-PCR
(Fig. 3) that tesA may be transcriptionally linked with
Rv2929 (unknown function), located upstream of fadD26
and the ppsA-E genes in the PDIM gene cluster (Fig. 1).
This RT-PCR analysis, to define the transcriptional organ-
ization of tesA, does not take into account the phenomenon
of transcriptional read-through.
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Disruption of drrB resulted in the loss of PDIM
production in M. tuberculosis. The drrA/B/C genes are
highly similar to daunorubicin ABC transporters found in
Streptomyces species; drrA codes for a nucleotide binding
domain and drrB/C encodes membrane-spanning domains
(Braibant et al. 2000). Camacho et al. (2001) described a
drrC mutant that was only reduced in PDIM production.
The PDIM in this mutant was localized mainly in the
cytosol and not in the cell wall or culture medium. The total
loss of PDIM in the drrBD, described here, may be
explained by the compensation of drrC function by the
products of drrA and drrB, which are located directly
upstream of drrC (Fig. 1). Indeed, increased resistance was
conferred to a number of antibiotics in Mycobacterium
smegmatis by the simultaneous expression of M. tuberculosis
drrA/B alone (Choudhuri et al. 2002). It is unclear why the
interruption of these transport-related genes affects the
generation of PDIM, when the disruption of mmpL7, which
codes for a conserved PDIM translocation membrane
protein does not (Cox et al. 1999). However, a polar effect
of the transposon insertion on the expression of the ppsA-E
gene products cannot be excluded.
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Fig. 3 Ethidium bromide stained 0Æ8% agarose electrophoresis gel of
products from the RT-PCR/PCR control reactions to determine the
presence of RNA between the tesA and Rv2929 open reading frames. A:
Hyperladder I electrophoresis markers from 10 000 to 200 bp; B, C:
PCR control reactions, using primers for an intragenic 975 bp product
in fadD26 (used in all control reactions) « Mycobacterium tuberculosis
DNA template; D, E: RT-PCR control reactions ± RT containing no
template RNA; F, G: RT-PCR control reactions ± RT containing
RNase-treated RNA; H, I: RT-PCR across the tesA-Rv2929 junc-
tion ± RT. A product of 680 bp was generated with the addition of RT
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Fig. 2 TLC of lipid extracts; nonpolar WT (A), tesAD (B), drrBD (C), pks11D (D); polar WT (E), pks6D (F). Plates were developed with solvent
system A (A–D) or E (E–F), according to Dobson et al. (1985), and sprayed with 5% ethanolic molybdophosphoric acid followed by charring. TAG,
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phosphatidylinositol; MPIDM and DPIDM, mono- and diacyl-phosphatidylinositol dimannosides; PIHM, phosphatidylinositol hexamannosides
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PDIM were not detectable in the M. tuberculosis pks11
transposon mutant. The pks11 gene codes for a putative
type III chalcone-like polyketide synthase. Chalcone
synthases catalyse the condensation of one coumaroyl-
CoA and three malonyl-CoA moieties to generate chalcone,
a secondary metabolite in the production of plant flavo-
noids and antifungal agents (Jez et al. 2001). Recently,
purified PKS11 and PKS18 have been demonstrated to
catalyse the formation of a-pyrones, using long-chain
aliphatic precursors in vitro (Saxena et al. 2003). The pks11
ORF is located in a cluster of pks genes in the M. tuber-
culosis genome (pks10/7/8/17/9/11). Of these genes, pks10
(a chalcone-like synthase) and pks7 have been identified to
be involved in PDIM generation in M. tuberculosis
(Rousseau et al. 2003; Sirakova et al. 2003a) and pks8/17
(msl5) has been implicated in the biosynthesis of mono-
methyl-branched unsaturated fatty acids (Dubey et al.
2003). The loss of PDIM generation in the pks11
transposon mutant suggests that the gene product of
pks11 is likely to be involved in the production of
precursor molecules necessary for successful PDIM gen-
eration in M. tuberculosis. As with other mutants identified
in putative polyketide synthase genes lacking PDIM, pks10,
pks7, pks12 (Sirakova et al. 2003b) and pks15/1 (Sirakova
et al. 2003a), pks11 probably plays a role in the biosyn-
thesis of phthiocerol or phenolphthiocerol. The potential
ring structures generated by the products of pks11 (and
putatively by pks10 and pks18) may be a distinct step in the
biosynthesis of phenolphthiocerol or it may be that the
chalcone-like polyketide synthases pks10 and pks11 provide
specificity for an additional range of starter molecules
during PDIM generation. Interestingly, Mycobacterium
leprae is able to generate PDIM although a number of
the polyketide genes, identified by gene knockouts to be
essential for PDIM production in M. tuberculosis, do not
appear to be functional. Numerous gene inactivation
studies demonstrate that PDIM are required for the
growth of M. tuberculosis in vivo (Camacho et al. 1999;
Cox et al. 1999; Rousseau et al. 2003; Sirakova et al. 2003a;
Sirakova et al. 2003b).
The loss of unknown polar lipids in the pks6D, compared
with WT M. tuberculosis, is significant, as the expression of
pks6 has been identified to be up-regulated in THP-1
phagocytosed-M. bovis BCG (Li et al. 2004). Additionally, a
pks6 transposon mutant is attenuated for growth in mouse
lung (Camacho et al. 1999). The true significance of this
finding will have to await the isolation and characterization
of these polar lipids from WT M. tuberculosis H37Rv. In
previous studies, M. tuberculosis H37Rv did not produce
corresponding lipids when cultivated on less-rich Sauton’s
medium (Minnikin et al. 1986). Growth media can have a
profound effect on mycobacterial polar lipid expression, as
exemplified by the enhanced production of a polar glycolipid
(Minnikin et al. 1989) in Mycobacterium marinum, when
grown on Middlebrook 7H9, in comparison with Sauton’s
(A.M. Burguie`re, M. Ridell, D.E. Minnikin and G.S. Besra,
unpublished data). Polar glycolipids of this type may include
methyl-branched acyl components, as found in the lipo-
oligosaccharides from the ‘Canetti’ variants ofM. tuberculosis
(Daffe´ et al. 1991); pks6 may be involved in the biosynthesis
of such branched fatty acids.
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